交易 Sana Biotechnology, Inc. - SANA CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Sana Biotechnology Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 17, 2024 | 8.24 | -0.20 | -2.37% | 8.44 | 8.57 | 8.13 |
Apr 16, 2024 | 8.38 | 0.15 | 1.82% | 8.23 | 8.58 | 8.09 |
Apr 15, 2024 | 8.54 | -0.41 | -4.58% | 8.95 | 9.13 | 8.51 |
Apr 12, 2024 | 8.93 | -0.21 | -2.30% | 9.14 | 9.52 | 8.78 |
Apr 11, 2024 | 9.34 | 0.30 | 3.32% | 9.04 | 9.34 | 8.93 |
Apr 10, 2024 | 8.97 | 0.13 | 1.47% | 8.84 | 9.01 | 8.69 |
Apr 9, 2024 | 9.32 | 0.32 | 3.56% | 9.00 | 9.33 | 8.82 |
Apr 8, 2024 | 9.08 | -0.01 | -0.11% | 9.09 | 9.16 | 8.78 |
Apr 5, 2024 | 8.97 | 0.58 | 6.91% | 8.39 | 9.04 | 8.24 |
Apr 4, 2024 | 8.48 | -0.77 | -8.32% | 9.25 | 9.34 | 8.43 |
Apr 3, 2024 | 9.13 | 0.46 | 5.31% | 8.67 | 9.18 | 8.59 |
Apr 2, 2024 | 8.79 | -0.76 | -7.96% | 9.55 | 9.63 | 8.73 |
Apr 1, 2024 | 10.10 | 0.21 | 2.12% | 9.89 | 10.15 | 9.76 |
Mar 28, 2024 | 9.96 | 0.02 | 0.20% | 9.94 | 10.09 | 9.74 |
Mar 27, 2024 | 9.97 | 0.51 | 5.39% | 9.46 | 9.98 | 9.19 |
Mar 26, 2024 | 9.43 | 0.34 | 3.74% | 9.09 | 9.53 | 8.98 |
Mar 25, 2024 | 9.07 | -0.07 | -0.77% | 9.14 | 9.57 | 8.94 |
Mar 22, 2024 | 9.12 | 0.08 | 0.88% | 9.04 | 9.26 | 8.85 |
Mar 21, 2024 | 9.12 | 0.02 | 0.22% | 9.10 | 9.36 | 8.96 |
Mar 20, 2024 | 8.93 | 0.44 | 5.18% | 8.49 | 8.99 | 8.39 |
Sana Biotechnology, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 6, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 Sana Biotechnology Inc Earnings Release Q1 2024 Sana Biotechnology Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 7, 2024 | ||
時間 (UTC) 16:00 | 國家 US
| 事件 Sana Biotechnology Inc Annual Shareholders Meeting Sana Biotechnology Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Thursday, August 1, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 Sana Biotechnology Inc Earnings Release Q2 2024 Sana Biotechnology Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 272.564 | 356.909 | 286.149 | 141.152 | 13.246 |
銷售/一般/行政費用,總計 | 71.561 | 50.41 | 27.77 | 21.177 | 4.206 |
研究與開發 | 285.885 | 248.626 | 257.879 | 119.375 | 9.04 |
營業收入 | -272.564 | -356.909 | -286.149 | -141.152 | -13.246 |
利息收入(費用),非經營淨值 | 3.762 | 0.676 | 0.747 | 2.856 | 0 |
其他,淨值 | -0.674 | 0.305 | 0.097 | -0.029 | -0.001 |
稅前淨收入 | -269.476 | -355.928 | -285.305 | -138.325 | -13.247 |
稅後淨收入 | -269.476 | -355.928 | -285.305 | -130.778 | -13.247 |
未計算非常項目前的淨收益 | -269.476 | -355.928 | -285.305 | -130.778 | -13.247 |
淨收入 | -269.476 | -355.928 | -285.305 | -130.778 | -13.247 |
普通股股東可獲收益 (不含非經常性項目) | -269.476 | -355.928 | -285.305 | -130.778 | -13.247 |
普通股股東可獲收益 (含非經常性項目) | -269.476 | -355.928 | -285.305 | -130.778 | -13.247 |
攤薄淨收入 | -269.476 | -355.928 | -285.305 | -130.778 | -13.247 |
攤薄後加權平均股 | 188.344 | 166.433 | 183.815 | 183.815 | 183.815 |
扣除特別項目的每股攤薄盈利 | -1.43076 | -2.13857 | -1.55213 | -0.71147 | -0.07207 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -1.43076 | -2.13857 | -1.54941 | -0.70934 | -0.07207 |
異常費用(收入) | 0.5 | 0.6 | |||
Other Operating Expenses, Total | -84.882 | 57.873 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 116.289 | 84.052 | 81.788 | 86.187 | 72.904 |
銷售/一般/行政費用,總計 | 16.566 | 16.766 | 23.321 | 15.514 | 18.292 |
研究與開發 | 73.044 | 67.166 | 63.921 | 76.735 | 72.54 |
Other Operating Expenses, Total | 26.679 | 0.12 | -5.454 | -6.062 | -17.928 |
營業收入 | -116.289 | -84.052 | -81.788 | -86.187 | -72.904 |
利息收入(費用),非經營淨值 | 2.374 | 1.976 | 1.613 | 1.173 | 0.637 |
其他,淨值 | -0.084 | -0.047 | -0.268 | -0.106 | -0.198 |
稅前淨收入 | -113.999 | -82.123 | -80.443 | -85.12 | -72.465 |
稅後淨收入 | -113.999 | -82.123 | -80.443 | -85.12 | -72.465 |
未計算非常項目前的淨收益 | -113.999 | -82.123 | -80.443 | -85.12 | -72.465 |
淨收入 | -113.999 | -82.123 | -80.443 | -85.12 | -72.465 |
Total Adjustments to Net Income | |||||
普通股股東可獲收益 (不含非經常性項目) | -113.999 | -82.123 | -80.443 | -85.12 | -72.465 |
普通股股東可獲收益 (含非經常性項目) | -113.999 | -82.123 | -80.443 | -85.12 | -72.465 |
攤薄淨收入 | -113.999 | -82.123 | -80.443 | -85.12 | -72.465 |
攤薄後加權平均股 | 192.54 | 191.228 | 190.441 | 189.303 | 187.626 |
扣除特別項目的每股攤薄盈利 | -0.59208 | -0.42945 | -0.4224 | -0.44965 | -0.38622 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.59208 | -0.42945 | -0.4224 | -0.44965 | -0.38622 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 444.437 | 558.101 | 384.467 | 144.263 | 32.596 |
現金和短期投資 | 423.963 | 550.996 | 378.264 | 138.982 | 30.63 |
現金等價物 | 176.765 | 253.029 | 124.806 | 80.03 | 30.63 |
短期投資 | 247.198 | 297.967 | 253.458 | 58.952 | 0 |
預付的費用 | 14.374 | 7.105 | 6.203 | 5.281 | 1.966 |
總資産 | 822.72 | 1129.41 | 730.296 | 415.192 | 34.333 |
物業/廠房/設備,總計 - 淨額 | 159.403 | 161.784 | 109.943 | 68.808 | 0.585 |
物業/廠房/設備,總計 - 總額 | 193.38 | 180.558 | 117.68 | 70.624 | 0.586 |
累計折舊,總計 | -33.977 | -18.774 | -7.737 | -1.816 | -0.001 |
商譽,淨額 | 140.627 | 140.627 | 140.627 | 140.627 | 0 |
無形資産,淨額 | 59.195 | 59.195 | 59.195 | 59.195 | 0 |
其他長期資産,總計 | 9.007 | 13.819 | 2.333 | 2.299 | 1.152 |
流動負債總額 | 111.504 | 99.235 | 31.451 | 19.323 | 1.785 |
應付賬款 | 2.857 | 2.219 | 2.253 | 0 | 0.289 |
預提費用 | 50.436 | 38.246 | 25.538 | 17.69 | 1.132 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 58.211 | 58.77 | 3.66 | 1.633 | 0.364 |
負債總額 | 323.405 | 400.905 | 298.583 | 140.375 | 1.8 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 211.901 | 301.67 | 267.132 | 121.052 | 0.015 |
股權 | 499.315 | 728.502 | 431.713 | 274.817 | 32.533 |
Redeemable Preferred Stock | 0 | 0 | 926.666 | 450.837 | 46.536 |
Preferred Stock - Non Redeemable, Net | -73.769 | -33.478 | -0.815 | ||
普通股 | 0.019 | 0.018 | 0.002 | 0.001 | 0.001 |
額外實收資本 | 1558.46 | 1515.21 | 8.216 | 1.558 | 0.058 |
留存收益(累計赤字) | -1054.84 | -785.36 | -429.432 | -144.127 | -13.247 |
其他權益,總計 | -4.327 | -1.366 | 0.03 | 0.026 | 0 |
總負債和股東權益 | 822.72 | 1129.41 | 730.296 | 415.192 | 34.333 |
已發行普通股總數 | 191.022 | 184.929 | 183.815 | 183.815 | 183.815 |
長期投資 | 10.051 | 195.881 | 33.731 | 0 | |
其他流動資産,總計 | 6.1 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 279.522 | 338.621 | 369.908 | 444.437 | 500.25 |
現金和短期投資 | 268.57 | 325.915 | 349.306 | 423.963 | 485.75 |
現金等價物 | 168.448 | 173.787 | 160.456 | 176.765 | 163.343 |
短期投資 | 100.122 | 152.128 | 188.85 | 247.198 | 322.407 |
預付的費用 | 7.12 | 6.606 | 14.502 | 14.374 | 8.4 |
總資産 | 631.44 | 707.147 | 746.928 | 822.72 | 898.102 |
物業/廠房/設備,總計 - 淨額 | 145.604 | 157.369 | 162.376 | 159.403 | 163.082 |
物業/廠房/設備,總計 - 總額 | 192.87 | 200.139 | 200.699 | 193.38 | 193.278 |
累計折舊,總計 | -47.266 | -42.77 | -38.323 | -33.977 | -30.196 |
商譽,淨額 | 140.627 | 140.627 | 140.627 | 140.627 | 140.627 |
無形資産,淨額 | 59.195 | 59.195 | 59.195 | 59.195 | 59.195 |
長期投資 | 0 | 0 | 5.825 | 10.051 | 25.823 |
其他長期資産,總計 | 6.492 | 11.335 | 8.997 | 9.007 | 9.125 |
流動負債總額 | 66.644 | 112.105 | 102.777 | 111.504 | 114.813 |
應付賬款 | 9.928 | 3.089 | 2.334 | 2.857 | 3.993 |
預提費用 | 54.645 | 47.175 | 40.981 | 50.436 | 49.143 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 2.071 | 61.841 | 59.462 | 58.211 | 61.677 |
負債總額 | 265.588 | 352.118 | 318.666 | 323.405 | 332.083 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 198.944 | 240.013 | 215.889 | 211.901 | 217.27 |
股權 | 365.852 | 355.029 | 428.262 | 499.315 | 566.019 |
普通股 | 0.02 | 0.02 | 0.019 | 0.019 | 0.019 |
額外實收資本 | 1616.01 | 1606.83 | 1567.34 | 1558.46 | 1546.81 |
留存收益(累計赤字) | -1249.97 | -1250.96 | -1136.96 | -1054.84 | -974.393 |
Unrealized Gain (Loss) | |||||
總負債和股東權益 | 631.44 | 707.147 | 746.928 | 822.72 | 898.102 |
已發行普通股總數 | 197.064 | 196.88 | 191.409 | 191.022 | 189.885 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
其他權益,總計 | -0.202 | -0.865 | -2.139 | -4.327 | -6.414 |
其他流動資産,總計 | 3.832 | 6.1 | 6.1 | 6.1 | 6.1 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -269.476 | -355.928 | -285.305 | -130.778 | -13.247 |
經營活動産生的現金 | -290.05 | -251.054 | -137.982 | -85.518 | -13.495 |
經營活動産生的現金 | 15.625 | 11.07 | 5.921 | 1.826 | 0.001 |
Deferred Taxes | 0 | 0 | -7.547 | 0 | |
非現金物品 | -43.741 | 84.003 | 135.246 | 40.469 | 0.059 |
營運資金的變化 | 7.542 | 9.801 | 6.156 | 10.512 | -0.308 |
投資活動産生的現金 | 210.562 | -245.798 | -252.563 | -87.861 | -0.78 |
資本支出 | -20.876 | -29.862 | -23.872 | -26.124 | -0.46 |
其他投資現金流量項目,總計 | 231.438 | -215.936 | -228.691 | -61.737 | -0.32 |
融資活動産生的現金 | 4.913 | 631.751 | 435.687 | 223.74 | 45.721 |
融資現金流項目 | 0 | 0 | |||
股票的發行(報廢),淨額 | 4.913 | 631.751 | 435.687 | 223.74 | 45.721 |
現金淨變化 | -74.575 | 134.899 | 45.142 | 50.361 | 31.446 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -82.123 | -269.476 | -189.033 | -103.913 | -31.448 |
Cash From Operating Activities | -79.272 | -290.05 | -213.983 | -149.187 | -77.709 |
Cash From Operating Activities | 4.346 | 15.625 | 11.43 | 7.414 | 3.614 |
Non-Cash Items | 9.312 | -43.741 | -49.51 | -53.744 | -46.514 |
Changes in Working Capital | -10.807 | 7.542 | 13.13 | 1.056 | -3.361 |
Cash From Investing Activities | 62.727 | 210.562 | 122.134 | 90.275 | 12.545 |
Capital Expenditures | -2.176 | -20.876 | -16.274 | -11.924 | -7.533 |
Other Investing Cash Flow Items, Total | 64.903 | 231.438 | 138.408 | 102.199 | 20.078 |
Cash From Financing Activities | 0.236 | 4.913 | 3.852 | 2.231 | 0.652 |
Issuance (Retirement) of Stock, Net | 0.236 | 4.913 | 3.852 | 2.231 | 0.652 |
Net Change in Cash | -16.309 | -74.575 | -87.997 | -56.681 | -64.512 |
Deferred Taxes |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
188 East Blaine Street, Suite 400
SEATTLE
WASHINGTON 98102
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易